Valuation: 10x Genomics, Inc.

Market Cap 9.13B 8.18B 7.53B 6.82B 12.75B 867B 12.98B 89.74B 36.02B 456B 34.28B 33.55B 1,439B P/E 2026 *
-95.9x
P/E 2027 * -99.6x
Enterprise Value 8.69B 7.78B 7.16B 6.49B 12.13B 825B 12.35B 85.37B 34.27B 434B 32.61B 31.92B 1,369B EV / Sales 2026 *
14x
EV / Sales 2027 * 12.6x
Free-Float
90.93%
Yield 2026 *
-
Yield 2027 * -
1 day-14.03%
1 week-2.01%
Current month-22.41%
1 month-22.41%
3 months+41.84%
6 months+217.96%
Current year+329.86%
1 week 67.42
Extreme 67.42
87.82
1 month 67.25
Extreme 67.25
102.81
Current year 15.9
Extreme 15.9
102.81
1 year 12.8
Extreme 12.8
102.81
3 years 6.78
Extreme 6.78
102.81
5 years 6.78
Extreme 6.78
187.85
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 01/07/2012
President 51 30/09/2012
Director of Finance/CFO 51 11/08/2024
Director TitleAgeSince
Director/Board Member 51 01/07/2012
Director/Board Member 49 01/07/2012
Chairman 68 31/07/2013
Date Insider Type Main position Quantity % Market Cap. Importance
22/09/26 Sell

Director

-5,723 0.0048%
22/09/26 Sell

Founder

-25,000 0.0208%
09/09/26 Sell

Chief Financial Officer

-46,388 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
-14.03%-2.01%+463.59%+96.11% 9.13B
+1.56%+2.41%-14.82%+14.19% 184B
-6.38%-4.98%-20.90%+11.15% 112B
-0.59%+1.18%+6.12%+37.97% 118B
+3.42%+1.71%-42.32%+9.52% 94.58B
+0.09%-0.05%-3.04%+78.44% 63.13B
-0.46%+0.42%+8.19%+82.97% 55.66B
-0.23%-0.52%+10.31%-21.19% 53.9B
-4.30%-1.64%-12.30%+39.06% 43.42B
+0.58%+2.00%-1.07%-6.43% 34.68B
Average -2.03%-0.15%+39.38%+34.18% 76.84B
Weighted average by Cap. -0.65%+0.21%-5.02%+26.06%

Financials

2026 *2027 *
Net sales 621M 556M 511M 463M 866M 58.92B 882M 6.1B 2.45B 31B 2.33B 2.28B 97.75B 683M 612M 563M 510M 953M 64.88B 971M 6.71B 2.69B 34.13B 2.56B 2.51B 108B
Net income -95.86M -85.85M -78.97M -71.55M -134M -9.1B -136M -942M -378M -4.79B -360M -352M -15.1B -90.23M -80.81M -74.33M -67.35M -126M -8.57B -128M -886M -356M -4.51B -339M -331M -14.21B
Net Debt -445M -398M -366M -332M -620M -42.21B -632M -4.37B -1.75B -22.2B -1.67B -1.63B -70.03B -527M -472M -434M -393M -735M -50.01B -749M -5.17B -2.08B -26.31B -1.98B -1.93B -82.97B
Projected Income Statement - Annual - 10x Genomics, Inc.
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.
Employees
1,178
Date Price Change Volume
30/10/26 US$70.11 -14.03% 5,218,776
29/10/26 US$81.55 -2.48% 1,860,047
28/10/26 US$83.62 +7.18% 5,047,435
27/10/26 US$78.02 +6.94% 2,129,136
26/10/26 US$72.96 +1.97% 1,413,121
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
MarketScreener Ratings - 10x Genomics, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
70.11USD
Average target price
77.50USD
Spread / Average Target
+10.54%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - 10x Genomics, Inc.